SUGAVILD® – M Tablet

SUGAVILD® – M is a fixed-dose combination of Vildagliptin, a DPP-4 inhibitor, and Metformin, a first-line insulin sensitizer. This dual-action formulation is designed for adult patients with type 2 diabetes mellitus (T2DM) who are inadequately controlled on monotherapy. It provides sustained blood glucose control by addressing both insulin resistance and incretin hormone regulation, with a low risk of hypoglycemia and no weight gain.

Categories: ,

Description

Composition (Each Film-Coated Tablet Contains):

  • Vildagliptin – 50 mg

  • Metformin Hydrochloride (Sustained Release) – 500 mg

Category: Diabetes Care / DPP-4 Inhibitor + Metformin Combination
Form: Oral Tablet
Pack Size: 10×10 Alu-Alu or Blister Pack


Product Description:

SUGAVILD® – M is a fixed-dose combination of Vildagliptin, a DPP-4 inhibitor, and Metformin, a first-line insulin sensitizer. This dual-action formulation is designed for adult patients with type 2 diabetes mellitus (T2DM) who are inadequately controlled on monotherapy. It provides sustained blood glucose control by addressing both insulin resistance and incretin hormone regulation, with a low risk of hypoglycemia and no weight gain.


Key Benefits:

  • Effectively lowers fasting and postprandial blood sugar

  • Enhances insulin sensitivity and pancreatic response

  • Low risk of hypoglycemia when not used with insulin

  • Weight-neutral and well-tolerated in long-term use

  • Ideal for newly diagnosed and early-stage type 2 diabetes patients


How it works:

  • Metformin works by reducing hepatic glucose production and increasing peripheral insulin sensitivity.

  • Vildagliptin inhibits DPP-4, preserving incretin hormones (GLP-1, GIP) that stimulate glucose-dependent insulin release and suppress excess glucagon.

Together, they offer synergistic control of blood glucose levels with excellent safety and tolerability.


How to use:

  • Take one tablet twice daily, preferably with meals, or as prescribed by your physician

  • Swallow whole with a full glass of water

  • Maintain proper diet, exercise, and hydration throughout treatment

  • Regular blood glucose and renal function monitoring is recommended


Safety Advice:

  • May cause mild gastrointestinal discomfort initially (due to Metformin)

  • Minimal risk of low blood sugar unless combined with sulfonylureas or insulin

  • Liver function should be assessed before starting and periodically

  • Stay hydrated to minimize GI and renal side effects


Precautions:

  • Not for use in type 1 diabetes or diabetic ketoacidosis (DKA)

  • Use with caution in patients with renal or liver dysfunction, heart failure, or alcohol misuse

  • Avoid during pregnancy and breastfeeding unless clearly advised

  • Inform your doctor about all current medications and supplements


Storage:

Store in a cool, dry place below 25°C.
Protect from light and moisture.
Keep out of reach of children.

Reviews

There are no reviews yet.

Be the first to review “SUGAVILD® – M Tablet”

Your email address will not be published. Required fields are marked *